CD44 and breast cancer: However, another study revealed that immobilised but not soluble HA enhanced co-localisation of CD44 and the receptor for hyaluronic acid-mediated motility (RHAMM), contributing to the aggressive and invasive phenotype in breast cancer cell lines [150].